From: Application of metabolomics in toxicity evaluation of traditional Chinese medicines
TCM | Toxicity | Animals | Samples | Metabolomic technology | Data analysis | Metabolic pathways | References |
---|---|---|---|---|---|---|---|
Aristolochic acid | Nephrotoxicity | Rats | Urine | GC–MS | PCA, PLS-DA | Energy metabolism, gut microbiota, purine metabolism | [60] |
Rats | Urine | LC–MS | OPLS-DA | Tricarboxylic acid cycle, gut microflora metabolism, amino acid metabolism, purine metabolism, bile acid biosynthesis | [61] | ||
Strychni Semen | Nephrotoxicity | Rats | Serum, urine | 1H NMR | OPLS-DA | Glycolysis, lipid and amino acid metabolism | [64] |
Arisaematis Rhizoma | Nephrotoxicity | Rats | Serum, urine | 1H NMR | PLS-DA | Glycolysis–gluconeogenesis, tricarboxylic acid cycle, fatty acid metabolism, gut microflora metabolism | [66] |
Pharbitidis Semen | Nephrotoxicity | Rats | Serum, kidney | LC–MS | PCA | Phospholipids metabolism, amino acid metabolism, sphingolipids biosynthesis and metabolism | [68] |
Rats | Urine | LC–MS | PCA | Amino acid metabolism, citric acid cycle, bile acid metabolism | [69] | ||
Alismatis Rhizoma | Chronic nephrotoxicity | Rats | Urine | LC–MS | PCA | Amino acid metabolism, Purine metabolism, bile acid metabolism, sphingolipids metabolism | [71] |